This article originally appeared on on April 6, 2020.
Germany, my home country, has gotten attention lately for doing some things right in its pandemic response. Diagnostic testing has been a key factor in keeping its death rate relatively low.
As a biotech entrepreneur, and with my PhD training in biomedical engineering, I want to think ahead about working on another useful idea the Germans, among others, are considering: Serology tests that look for protective antibodies against the SARS-CoV-2 virus.
To read the full article, .